Latest News

  • INNOVATION

    6 Feb 2026

    AI Alliances Are Reshaping Peptide Manufacturing in America

  • MARKET TRENDS

    5 Feb 2026

    Why Peptide Drugmakers Are Betting Big on Factories

  • TECHNOLOGY

    4 Feb 2026

    Can Algorithms Outrun the Lab in Peptide Discovery?

  • PARTNERSHIPS

    3 Feb 2026

    A Peptide Merger That Reflects Biotech’s New Priorities

A New Weapon Against Implant Infections Takes Shape

Biomedical researchers examining peptide-based implant protection methods

INSIGHTS

2 Feb 2026

Peptide therapies advance into pivotal Phase 2/3 trials, pointing to a new way to prevent implant infections if results and approvals follow

Scientist examining samples under a microscope in a pharmaceutical lab

INNOVATION

6 Feb 2026

AI Alliances Are Reshaping Peptide Manufacturing in America

Grace and Molecule.one apply AI and automation to ease peptide bottlenecks, signaling a shift toward faster, more resilient US drug manufa...

Pharmaceutical manufacturing facility with large stainless steel production tanks

MARKET TRENDS

5 Feb 2026

Why Peptide Drugmakers Are Betting Big on Factories

Soaring demand is forcing peptide drugmakers to rethink strategy, shifting focus from discovery toward manufacturing scale, reliability, a...

Concept illustration of generative AI applied to peptide discovery

TECHNOLOGY

4 Feb 2026

Can Algorithms Outrun the Lab in Peptide Discovery?

Generative AI platforms like Menten AI’s MAUD 1.0 are speeding early peptide discovery, helping biotech firms make smarter design decision...

Prescription pill bottles and capsules representing peptide drug development

PARTNERSHIPS

3 Feb 2026

A Peptide Merger That Reflects Biotech’s New Priorities

Completed in Nov 2025, the Salarius and Decoy deal creates Decoy Therapeutics with $14M and an AI-first peptide platform

Biomedical researchers examining peptide-based implant protection methods

INSIGHTS

2 Feb 2026

A New Weapon Against Implant Infections Takes Shape

Peptide therapies advance into pivotal Phase 2/3 trials, pointing to a new way to prevent implant infections if results and approvals foll...

Pills and syringe representing competing cholesterol drug delivery methods

RESEARCH

30 Jan 2026

Can Peptide Pills Finally Challenge Cholesterol Injections?

Phase 3 data suggest oral peptide drugs could rival injectables for lowering LDL cholesterol, pointing to a future shift if approvals and ...

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.